IBDEI2QE ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,43552,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43552,1,3,0)
;;=3^Hemiplegia Affecting Lt Non-Dominant Side
;;^UTILITY(U,$J,358.3,43552,1,4,0)
;;=4^I69.954
;;^UTILITY(U,$J,358.3,43552,2)
;;=^5133587
;;^UTILITY(U,$J,358.3,43553,0)
;;=I69.941^^160^2124^39
;;^UTILITY(U,$J,358.3,43553,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43553,1,3,0)
;;=3^Monoplegia of Lower Limb Affecting Rt Dominant Side
;;^UTILITY(U,$J,358.3,43553,1,4,0)
;;=4^I69.941
;;^UTILITY(U,$J,358.3,43553,2)
;;=^5133581
;;^UTILITY(U,$J,358.3,43554,0)
;;=I69.942^^160^2124^37
;;^UTILITY(U,$J,358.3,43554,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43554,1,3,0)
;;=3^Monoplegia of Lower Limb Affecting Lt Dominant Side
;;^UTILITY(U,$J,358.3,43554,1,4,0)
;;=4^I69.942
;;^UTILITY(U,$J,358.3,43554,2)
;;=^5133582
;;^UTILITY(U,$J,358.3,43555,0)
;;=I69.943^^160^2124^40
;;^UTILITY(U,$J,358.3,43555,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43555,1,3,0)
;;=3^Monoplegia of Lower Limb Affecting Rt Non-Dominant Side
;;^UTILITY(U,$J,358.3,43555,1,4,0)
;;=4^I69.943
;;^UTILITY(U,$J,358.3,43555,2)
;;=^5133584
;;^UTILITY(U,$J,358.3,43556,0)
;;=I69.944^^160^2124^38
;;^UTILITY(U,$J,358.3,43556,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43556,1,3,0)
;;=3^Monoplegia of Lower Limb Affecting Lt Non-Dominant Side
;;^UTILITY(U,$J,358.3,43556,1,4,0)
;;=4^I69.944
;;^UTILITY(U,$J,358.3,43556,2)
;;=^5133585
;;^UTILITY(U,$J,358.3,43557,0)
;;=I69.928^^160^2124^47
;;^UTILITY(U,$J,358.3,43557,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43557,1,3,0)
;;=3^Speech/Lang Deficits s/p Unspec Cerebrov Dis
;;^UTILITY(U,$J,358.3,43557,1,4,0)
;;=4^I69.928
;;^UTILITY(U,$J,358.3,43557,2)
;;=^5007557
;;^UTILITY(U,$J,358.3,43558,0)
;;=I69.961^^160^2124^43
;;^UTILITY(U,$J,358.3,43558,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43558,1,3,0)
;;=3^Paralytic Syndrome Affecting Rt Dominant Side
;;^UTILITY(U,$J,358.3,43558,1,4,0)
;;=4^I69.961
;;^UTILITY(U,$J,358.3,43558,2)
;;=^5007564
;;^UTILITY(U,$J,358.3,43559,0)
;;=I69.962^^160^2124^41
;;^UTILITY(U,$J,358.3,43559,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43559,1,3,0)
;;=3^Paralytic Syndrome Affecting Lt Dominant Side
;;^UTILITY(U,$J,358.3,43559,1,4,0)
;;=4^I69.962
;;^UTILITY(U,$J,358.3,43559,2)
;;=^5133588
;;^UTILITY(U,$J,358.3,43560,0)
;;=I69.963^^160^2124^44
;;^UTILITY(U,$J,358.3,43560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43560,1,3,0)
;;=3^Paralytic Syndrome Affecting Rt Non-Dominant Side
;;^UTILITY(U,$J,358.3,43560,1,4,0)
;;=4^I69.963
;;^UTILITY(U,$J,358.3,43560,2)
;;=^5007565
;;^UTILITY(U,$J,358.3,43561,0)
;;=I69.964^^160^2124^42
;;^UTILITY(U,$J,358.3,43561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43561,1,3,0)
;;=3^Paralytic Syndrome Affecting Lt Non-Dominant Side
;;^UTILITY(U,$J,358.3,43561,1,4,0)
;;=4^I69.964
;;^UTILITY(U,$J,358.3,43561,2)
;;=^5133589
;;^UTILITY(U,$J,358.3,43562,0)
;;=I69.965^^160^2124^45
;;^UTILITY(U,$J,358.3,43562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43562,1,3,0)
;;=3^Paralytic Syndrome,Bilateral
;;^UTILITY(U,$J,358.3,43562,1,4,0)
;;=4^I69.965
;;^UTILITY(U,$J,358.3,43562,2)
;;=^5007566
;;^UTILITY(U,$J,358.3,43563,0)
;;=I69.90^^160^2124^51
;;^UTILITY(U,$J,358.3,43563,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,43563,1,3,0)
;;=3^Unspec Sequelae of Unspec Cerebrov Dis
;;^UTILITY(U,$J,358.3,43563,1,4,0)
;;=4^I69.90
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2QE 3783 printed Apr 09, 2024@21:33 Page 2
IBDEI2QE ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,43552,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,43552,1,3,0)
+4 ;;=3^Hemiplegia Affecting Lt Non-Dominant Side
+5 ;;^UTILITY(U,$J,358.3,43552,1,4,0)
+6 ;;=4^I69.954
+7 ;;^UTILITY(U,$J,358.3,43552,2)
+8 ;;=^5133587
+9 ;;^UTILITY(U,$J,358.3,43553,0)
+10 ;;=I69.941^^160^2124^39
+11 ;;^UTILITY(U,$J,358.3,43553,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,43553,1,3,0)
+14 ;;=3^Monoplegia of Lower Limb Affecting Rt Dominant Side
+15 ;;^UTILITY(U,$J,358.3,43553,1,4,0)
+16 ;;=4^I69.941
+17 ;;^UTILITY(U,$J,358.3,43553,2)
+18 ;;=^5133581
+19 ;;^UTILITY(U,$J,358.3,43554,0)
+20 ;;=I69.942^^160^2124^37
+21 ;;^UTILITY(U,$J,358.3,43554,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,43554,1,3,0)
+24 ;;=3^Monoplegia of Lower Limb Affecting Lt Dominant Side
+25 ;;^UTILITY(U,$J,358.3,43554,1,4,0)
+26 ;;=4^I69.942
+27 ;;^UTILITY(U,$J,358.3,43554,2)
+28 ;;=^5133582
+29 ;;^UTILITY(U,$J,358.3,43555,0)
+30 ;;=I69.943^^160^2124^40
+31 ;;^UTILITY(U,$J,358.3,43555,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,43555,1,3,0)
+34 ;;=3^Monoplegia of Lower Limb Affecting Rt Non-Dominant Side
+35 ;;^UTILITY(U,$J,358.3,43555,1,4,0)
+36 ;;=4^I69.943
+37 ;;^UTILITY(U,$J,358.3,43555,2)
+38 ;;=^5133584
+39 ;;^UTILITY(U,$J,358.3,43556,0)
+40 ;;=I69.944^^160^2124^38
+41 ;;^UTILITY(U,$J,358.3,43556,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,43556,1,3,0)
+44 ;;=3^Monoplegia of Lower Limb Affecting Lt Non-Dominant Side
+45 ;;^UTILITY(U,$J,358.3,43556,1,4,0)
+46 ;;=4^I69.944
+47 ;;^UTILITY(U,$J,358.3,43556,2)
+48 ;;=^5133585
+49 ;;^UTILITY(U,$J,358.3,43557,0)
+50 ;;=I69.928^^160^2124^47
+51 ;;^UTILITY(U,$J,358.3,43557,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,43557,1,3,0)
+54 ;;=3^Speech/Lang Deficits s/p Unspec Cerebrov Dis
+55 ;;^UTILITY(U,$J,358.3,43557,1,4,0)
+56 ;;=4^I69.928
+57 ;;^UTILITY(U,$J,358.3,43557,2)
+58 ;;=^5007557
+59 ;;^UTILITY(U,$J,358.3,43558,0)
+60 ;;=I69.961^^160^2124^43
+61 ;;^UTILITY(U,$J,358.3,43558,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,43558,1,3,0)
+64 ;;=3^Paralytic Syndrome Affecting Rt Dominant Side
+65 ;;^UTILITY(U,$J,358.3,43558,1,4,0)
+66 ;;=4^I69.961
+67 ;;^UTILITY(U,$J,358.3,43558,2)
+68 ;;=^5007564
+69 ;;^UTILITY(U,$J,358.3,43559,0)
+70 ;;=I69.962^^160^2124^41
+71 ;;^UTILITY(U,$J,358.3,43559,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,43559,1,3,0)
+74 ;;=3^Paralytic Syndrome Affecting Lt Dominant Side
+75 ;;^UTILITY(U,$J,358.3,43559,1,4,0)
+76 ;;=4^I69.962
+77 ;;^UTILITY(U,$J,358.3,43559,2)
+78 ;;=^5133588
+79 ;;^UTILITY(U,$J,358.3,43560,0)
+80 ;;=I69.963^^160^2124^44
+81 ;;^UTILITY(U,$J,358.3,43560,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,43560,1,3,0)
+84 ;;=3^Paralytic Syndrome Affecting Rt Non-Dominant Side
+85 ;;^UTILITY(U,$J,358.3,43560,1,4,0)
+86 ;;=4^I69.963
+87 ;;^UTILITY(U,$J,358.3,43560,2)
+88 ;;=^5007565
+89 ;;^UTILITY(U,$J,358.3,43561,0)
+90 ;;=I69.964^^160^2124^42
+91 ;;^UTILITY(U,$J,358.3,43561,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,43561,1,3,0)
+94 ;;=3^Paralytic Syndrome Affecting Lt Non-Dominant Side
+95 ;;^UTILITY(U,$J,358.3,43561,1,4,0)
+96 ;;=4^I69.964
+97 ;;^UTILITY(U,$J,358.3,43561,2)
+98 ;;=^5133589
+99 ;;^UTILITY(U,$J,358.3,43562,0)
+100 ;;=I69.965^^160^2124^45
+101 ;;^UTILITY(U,$J,358.3,43562,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,43562,1,3,0)
+104 ;;=3^Paralytic Syndrome,Bilateral
+105 ;;^UTILITY(U,$J,358.3,43562,1,4,0)
+106 ;;=4^I69.965
+107 ;;^UTILITY(U,$J,358.3,43562,2)
+108 ;;=^5007566
+109 ;;^UTILITY(U,$J,358.3,43563,0)
+110 ;;=I69.90^^160^2124^51
+111 ;;^UTILITY(U,$J,358.3,43563,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,43563,1,3,0)
+114 ;;=3^Unspec Sequelae of Unspec Cerebrov Dis
+115 ;;^UTILITY(U,$J,358.3,43563,1,4,0)
+116 ;;=4^I69.90
